5-Azacytidine [320-67-2]

Commande minimum 2

Référence T1339-1ml

Conditionnement : 1mLx10mM(inDMSO)

Marque : TargetMol


5-Azacytidine (Synonyms: NSC 102816, Mylosar, Ladakamycin, Azacitidine, 5-AzaC)

5-Azacytidine

Copy Product Info
Synonyms NSC 102816, Mylosar, Ladakamycin, Azacitidine, 5-AzaC
5-Azacytidine
Cas No. 320-67-2
For research use only—not for human use. No sales to individuals. Use as intended only.
Select Batch
Purity:99.87%
Color:White
COA LCMS HNMR

Product Introduction

Bioactivity
Description
5-Azacytidine (Ladakamycin) is a cytidine nucleoside analog, a DNA methylation inhibitor with specificity. 5-Azacytidine regulates gene expression by decreasing the level of DNA methylation. 5-Azacytidine induces autophagy and has antitumor activity.
Targets&IC50
5637 cells viability:1.73 ± 1.20 μM, A427 cells viability:0.63 ± 0.05 μM, MCF-7 cells viability:6.78 ± 5.21 μM, KYSE70 cells viability:1.59 ± 1.93 μM
In vitro
In leukemic BDF1 mice bearing L1210 ascitic tumor cells, intraperitoneal administration of Azacitidine (3 mg/kg) inhibits polynucleotide synthesis and prolongs survival time.
In vivo
In both regular eukaryotic cells and cancer cells, Azacitidine activates nucleoside triphosphates and inhibits the synthesis of DNA, RNA, and proteins, ultimately leading to cell death. Azacitidine induces cell differentiation and myotube formation in C3H10T1/2 cells. Additionally, Azacitidine suppresses cell growth in L1210 cells (IC50=0.019 μg/mL).
Kinase Assay
A crude cell-free extract is isolated from LI 210 cells in culture by suspension of the cells in a given volume of 0.05mol/LTris-HCl buffer, pH 7.4, and sonic extraction with a Biosonik at 70% maximal output for 30 sec. The supernatant is collected after centrifugation at 105,000 × g for 60 min (4°C) in a Model L Spinco ultracentrifuge. The final protein concentration of the cell-free extracts is approximately 3 mg/mL. The extracts are used as the source of enzymes. Ribonucleotide reductase activity is measured. A unit of enzyme is defined as the amount that catalyzed dCMP synthesis at a rate of 1 mμmole/hr. The assay systems for the measurement of pyrimidine nucleoside (CR) and deoxynucleoside (TdR, CdR) kinases are essentially those described by Chu and Fischer. However, reactions are terminated by heating for 2 min in a boiling water bath, and the phosphorylated derivatives are isolated according to the method of Bach. Fifty-jul aliquots are applied to 1-inch discs of diethylaminoethyl paper, which are then placed in counting vials and eluted with 0.5 mL of 0.5 mol/LPCA. After 1 hr, 12 mL of Diotol are added, and the radioactivity is determined.
Cell Research
5 mL of L1210 cells (5 × 103 cells/mL) are incubated with Azacitidine at 37 ℃ for 3 days. Cell number is determined twice a day for 3 days by means of a Model A Coulter counter.(Only for Reference)
SynonymsNSC 102816, Mylosar, Ladakamycin, Azacitidine, 5-AzaC
Chemical Properties
Molecular Weight244.2
FormulaC8H12N4O5
Cas No.320-67-2
SmilesO[C@H]1[C@@H](O[C@H](CO)[C@H]1O)N2C(=O)N=C(N)N=C2
Relative Density.2.08 g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year
Solubility Information
DMSO: 262.5 mg/mL (1074.94 mM), Sonication is recommended.
H2O: 10 mg/mL (40.95 mM), Sonication and heating are recommended.
In Vivo Formulation
PBS: 10 mg/mL (40.95 mM), Sonication and heating are recommended.
5% DMSO+40% PEG300+5% Tween 80+50% Saline: 1 mg/mL (4.1 mM), Solution.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
H2O/DMSO
1mg5mg10mg50mg
1 mM4.0950 mL20.4750 mL40.9500 mL204.7502 mL
5 mM0.8190 mL4.0950 mL8.1900 mL40.9500 mL
10 mM0.4095 mL2.0475 mL4.0950 mL20.4750 mL
20 mM0.2048 mL1.0238 mL2.0475 mL10.2375 mL
DMSO
1mg5mg10mg50mg
50 mM0.0819 mL0.4095 mL0.8190 mL4.0950 mL
100 mM0.0410 mL0.2048 mL0.4095 mL2.0475 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Vous serez peut-être également intéressé par les produits suivants :



Référence
Description
Cond.
Prix HT
T2383-10mg
 10mg 
T2125-1ml
 1mLx10mM(inDMSO) 
T2383-50mg
 50mg